4.5 Review

Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State of the Art and Perspectives

Journal

FRONTIERS IN PEDIATRICS
Volume 7, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fped.2019.00443

Keywords

gene therapy; SCID; thalassemia; sickle cell disease; gene editing; lysosomal storage disorder; clinical trial; curative treatment

Categories

Funding

  1. EU H2020 grant SCIDNET
  2. EU H2020 grant RECOMB
  3. Fondazione Telethon
  4. E-rare EUROCID
  5. European Union's Horizon 2020 research and innovation program

Ask authors/readers for more resources

Gene therapy using patient's own stem cells is rapidly becoming an alternative to allogeneic stem cell transplantation, especially when suitably compatible donors cannot be found. The advent of efficient virus-based methods for delivering therapeutic genes has enabled the development of genetic medicines for inherited disorders of the immune system, hemoglobinopathies, and a number of devastating metabolic diseases. Here, we briefly review the state of the art in the field, including gene editing approaches. A growing number of pediatric diseases can be successfully cured by hematopoietic stem-cell-based gene therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available